Recently, IGF2BP2 was shown to promote CRC progression by stabilizing oncogenic mRNAs, including YAP mRNA [33], a downstream nuclear effector of the Hippo signaling pathway with a role in the development and progression of multiple cancers. This evidence concerns the gene IGF2BP2 and colorectal carcinoma.